Literature DB >> 3632663

Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate.

J G Léger, M L Montpetit, M P Tenniswood.   

Abstract

The involution of the prostate that occurs after castration is thought to be an active process, requiring protein synthesis. A number of "castration-induced" proteins which might be involved in this process have been identified. We recently described a group of "testosterone-repressed" mRNA sequences in the prostate which could code for these proteins. Because of their potential importance in the autophagic response we have cloned these sequences, and we report here the characterization of the most abundant of these sequences (TRPM-2), and the kinetics of the induction of this gene in the prostate after castration. TRPM-2 is induced to a maximum level of approximately 1440 ppm of total RNA six days after castration, by which time the androgen dependent, prostate steroid binding protein (PSBP) mRNA sequences have diminished to undetectable levels. The translation product of TRPM-2 is a protein of approximately 46,000 daltons, with a pI of 5.9-6.3. Since this gene is expressed in other involuting tissues, it may play an important role in the process of tissue regression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3632663     DOI: 10.1016/s0006-291x(87)80106-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

Review 1.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Rapid induction of apoptosis in rat liver by cycloheximide.

Authors:  G M Ledda-Columbano; P Coni; G Faa; G Manenti; A Columbano
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

Review 3.  Clusterin and chemoresistance.

Authors:  Julie Y Djeu; Sheng Wei
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

4.  Chromosome assignments of the genes for glucocorticoid receptor, myelin basic protein, leukocyte common antigen, and TRPM2 in the rat.

Authors:  A Goldner-Sauvé; C Szpirer; J Szpirer; G Levan; D L Gasser
Journal:  Biochem Genet       Date:  1991-06       Impact factor: 1.890

5.  Post-castration rebound of an androgen regulated prostatic gene.

Authors:  R Sweetland; P C Sheppard; J G Dodd; R J Matusik
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

6.  Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.

Authors:  Thomas W Czeczok; Kristen M Stashek; Jessica E Maxwell; Thomas M O'Dorisio; James R Howe; Jason L Hornick; Andrew M Bellizzi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-02

7.  Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.

Authors:  S N Freeman; P S Rennie; J Chao; L R Lund; P A Andreasen
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

8.  Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis.

Authors:  S Bettuzzi; R A Hiipakka; P Gilna; S T Liao
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

9.  Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death.

Authors:  M Danik; J G Chabot; C Mercier; A L Benabid; C Chauvin; R Quirion; M Suh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report.

Authors:  M R Pins; J E Fiadjoe; F Korley; M Wong; A W Rademaker; B Jovanovic; T K Yoo; J M Kozlowski; A Raji; X J Yang; C Lee
Journal:  Prostate Cancer Prostatic Dis       Date:  2004       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.